GCKR common functional polymorphisms are associated with metabolic syndrome and its components: a 10-year retrospective cohort study in Iranian adults.
GCKR
Metabolic syndrome
Single nucleotide polymorphisms
Triglyceride
Journal
Diabetology & metabolic syndrome
ISSN: 1758-5996
Titre abrégé: Diabetol Metab Syndr
Pays: England
ID NLM: 101488958
Informations de publication
Date de publication:
18 Feb 2021
18 Feb 2021
Historique:
received:
27
12
2020
accepted:
08
02
2021
entrez:
19
2
2021
pubmed:
20
2
2021
medline:
20
2
2021
Statut:
epublish
Résumé
Previous studies reported that common functional variants (rs780093, rs780094, and rs1260326) in the glucokinase regulator gene (GCKR) were associated with metabolic syndrome despite the simultaneous association with the favorable and unfavorable metabolic syndrome components. We decided to evaluate these findings in a cohort study with a large sample size of Iranian adult subjects, to our knowledge for the first time. We investigated the association of the GCKR variants with incident MetS in mean follow-up times for nearly 10 years. Analysis of this retrospective cohort study was performed among 5666 participants of the Tehran Cardiometabolic Genetics Study (TCGS) at 19-88 years at baseline. Linear and logistic regression analyses were used to investigate the metabolic syndrome (JIS criteria) association and its components with rs780093, rs780094, and rs1260326 in an additive genetic model. Cox regression was carried out to peruse variants' association with the incidence of metabolic syndrome in the TCGS cohort study. In the current study, we have consistently replicated the association of the GCKR SNPs with higher triglyceride and lower fasting blood sugar levels (p < 0.05) in Iranian adults. The CT genotype of the variants was associated with lower HDL-C levels. The proportional Cox adjusted model regression resulted that TT carriers of rs780094, rs780093, and rs1260326 were associated with 20%, 23%, and 21% excess risk metabolic syndrome incidence, respectively (p < 0.05). Elevated triglyceride levels had the strongest association with GCKR selected variants among the metabolic syndrome components. Despite the association of these variants with decreased fasting blood sugar levels, T alleles of the variants were associated with metabolic syndrome incidence; so whether individuals are T allele carriers of the common functional variants, they have a risk factor for the future incidence of metabolic syndrome.
Sections du résumé
BACKGROUND
BACKGROUND
Previous studies reported that common functional variants (rs780093, rs780094, and rs1260326) in the glucokinase regulator gene (GCKR) were associated with metabolic syndrome despite the simultaneous association with the favorable and unfavorable metabolic syndrome components. We decided to evaluate these findings in a cohort study with a large sample size of Iranian adult subjects, to our knowledge for the first time. We investigated the association of the GCKR variants with incident MetS in mean follow-up times for nearly 10 years.
METHODS
METHODS
Analysis of this retrospective cohort study was performed among 5666 participants of the Tehran Cardiometabolic Genetics Study (TCGS) at 19-88 years at baseline. Linear and logistic regression analyses were used to investigate the metabolic syndrome (JIS criteria) association and its components with rs780093, rs780094, and rs1260326 in an additive genetic model. Cox regression was carried out to peruse variants' association with the incidence of metabolic syndrome in the TCGS cohort study.
RESULTS
RESULTS
In the current study, we have consistently replicated the association of the GCKR SNPs with higher triglyceride and lower fasting blood sugar levels (p < 0.05) in Iranian adults. The CT genotype of the variants was associated with lower HDL-C levels. The proportional Cox adjusted model regression resulted that TT carriers of rs780094, rs780093, and rs1260326 were associated with 20%, 23%, and 21% excess risk metabolic syndrome incidence, respectively (p < 0.05).
CONCLUSIONS
CONCLUSIONS
Elevated triglyceride levels had the strongest association with GCKR selected variants among the metabolic syndrome components. Despite the association of these variants with decreased fasting blood sugar levels, T alleles of the variants were associated with metabolic syndrome incidence; so whether individuals are T allele carriers of the common functional variants, they have a risk factor for the future incidence of metabolic syndrome.
Identifiants
pubmed: 33602293
doi: 10.1186/s13098-021-00637-4
pii: 10.1186/s13098-021-00637-4
pmc: PMC7890822
doi:
Types de publication
Journal Article
Langues
eng
Pagination
20Subventions
Organisme : Shahid Beheshti University of Medical Sciences
ID : 12228
Commentaires et corrections
Type : ErratumIn
Références
Diabetes. 1996 Feb;45(2):223-41
pubmed: 8549869
Diabetes. 2011 Apr;60(4):1329-39
pubmed: 21386085
JMIR Res Protoc. 2017 Feb 23;6(2):e28
pubmed: 28232301
Diabetes. 1999 Oct;48(10):2022-7
pubmed: 10512368
Endocr J. 2014;61(7):683-9
pubmed: 24785259
Arch Iran Med. 2010 May;13(3):243-4
pubmed: 20433230
Eur J Biochem. 1989 Jan 15;179(1):179-84
pubmed: 2917560
PLoS Genet. 2013 Jun;9(6):e1003556
pubmed: 23818862
PLoS One. 2010 Jul 22;5(7):e11690
pubmed: 20661421
Eur J Clin Nutr. 2010 Oct;64(10):1207-14
pubmed: 20588290
J Res Med Sci. 2018 Feb 20;23:11
pubmed: 29531563
Diabetes Care. 2009 Jun;32(6):1092-7
pubmed: 19279302
Diabetologia. 2005 Sep;48(9):1684-99
pubmed: 16079964
J Am Coll Cardiol. 2010 Sep 28;56(14):1113-32
pubmed: 20863953
Mamm Genome. 1995 Aug;6(8):532-6
pubmed: 8589523
Diabetologia. 2011 Apr;54(4):783-8
pubmed: 21188353
Nat Genet. 2015 Jun;47(6):589-97
pubmed: 25961943
Diabetologia. 2003 May;46(5):704-11
pubmed: 12739015
Circ Cardiovasc Genet. 2012 Apr 1;5(2):242-9
pubmed: 22399527
Diabetes. 2008 Aug;57(8):2253-7
pubmed: 18556336
PLoS One. 2020 Jan 7;15(1):e0227357
pubmed: 31910446
Nat Genet. 2009 Jan;41(1):56-65
pubmed: 19060906
Trials. 2009 Jan 25;10:5
pubmed: 19166627
Nat Genet. 2010 Feb;42(2):105-16
pubmed: 20081858
Diabetes. 1998 Mar;47(3):307-15
pubmed: 9519733
J Clin Med. 2020 Nov 11;9(11):
pubmed: 33187372
Diabetes Metab Syndr. 2019 Jan - Feb;13(1):792-799
pubmed: 30641809
Science. 2007 Jun 1;316(5829):1331-6
pubmed: 17463246
Clin Chem Lab Med. 2011 May;49(5):897-901
pubmed: 21288172
Hum Mol Genet. 2011 Nov 15;20(22):4504-14
pubmed: 21862451
Nutr Res. 2018 Dec;60:96-105
pubmed: 30527264
Circulation. 2002 Jul 16;106(3):286-8
pubmed: 12119239
Clin Biochem. 2018 Apr;54:68-72
pubmed: 29486186
Biochem Med (Zagreb). 2019 Jun 15;29(2):020901
pubmed: 31223265
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
PLoS One. 2015 Nov 24;10(11):e0143607
pubmed: 26599349
Nat Genet. 2010 Mar;42(3):210-5
pubmed: 20139978
Genet Test Mol Biomarkers. 2016 Mar;20(3):137-42
pubmed: 26799416
Clin Biochem. 2018 Aug;58:1-4
pubmed: 29698621
Diabetologia. 2012 Jan;55(1):114-22
pubmed: 22038520
BMC Res Notes. 2020 Jan 10;13(1):26
pubmed: 31924263
Cardiovasc Diabetol. 2010 Nov 29;9:79
pubmed: 21114848
Diabetes. 2008 Nov;57(11):3112-21
pubmed: 18678614
Hum Mol Genet. 2009 Nov 1;18(21):4081-8
pubmed: 19643913
Mol Cell Endocrinol. 2014 Jan 25;382(1):740-757
pubmed: 22963884
Int J Appl Basic Med Res. 2015 May-Aug;5(2):133-8
pubmed: 26097823